Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venture Capital for Research and Technology (VCRT) is an Egyptian investment firm dedicated to commercializing scientific innovations and bridging the gap between academia and industry. Established as a joint-stock company, it is backed by the Academy of Scientific Research and Technology (ASRT) alongside major Egyptian financial institutions like the National Bank of Egypt and Banque Misr. The company primarily focuses on funding startups and projects within the biotechnology, healthcare, pharmaceuticals, and engineering sectors. VCRT provides not only financial capital but also strategic mentorship and technical support to help researchers navigate the path from laboratory discovery to market entry. By fostering a robust innovation ecosystem, the firm aims to enhance Egypt's technological self-sufficiency and economic growth through high-value research-driven enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VC for Research and Technology.